Insiders ReShape Lifesciences Inc.

Equities

RSLS

US76090R2004

Market Closed - Nasdaq Other stock markets 21:00:00 13/05/2024 BST			5-day change	1st Jan Change
0.167 ^USD	-0.60%		-0.18%	-33.12%

04-12	North American Morning Briefing : Big Banks Kick -2-	DJ
04-01	Transcript : ReShape Lifesciences Inc., Q4 2023 Earnings Call, Apr 01, 2024

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Reshape Lifesciences Announces Formation of International Scientific Advisory Board	23/03/23	CI
Reshape Lifesciences Inc. Appoints Nick Ansari, as Senior Vice President of Global Commercial Operations	23/08/22	CI
ReShape Lifesciences Appoints Paul F. Hickey as President and Member of the Board of Directors, Effective August 15, 2022	27/07/22	CI
ReShape Lifesciences Appoints Paul F. Hickey as Chief Executive Officer, Effective August 15, 2022	27/07/22	CI
ReShape Lifesciences Inc. Appoints Michael Bordainick as Senior Vice President, Commercial Operations	13/01/22	CI
Insider Trends: Insider 90-Day Selling Trend Extended at ReShape Lifesciences	22/06/21	MT
Obalon Therapeutics, Inc. has Changed its Name to ReShape Lifesciences Inc	15/06/21	CI
Obalon Therapeutics, Inc. Announces Resignation of David Moatazedi as Member of the Board, the Compensation Committee, and the Audit Committee	02/07/20	CI
Obalon Therapeutics, Inc. Appoints Kim Kamdar as Chairperson of the Board of Directors	30/06/20	CI
Obalon Therapeutics, Inc. Announces Management Changes	08/05/20	CI
Obalon Therapeutics, Inc. Appoints William J. Plovanic as Chief Executive Officer and Nooshin Hussainy as Chief Financial Officer	24/10/19	CI
Obalon Therapeutics, Inc. Appoints Helmuth T. Billy as Medical Director	03/09/19	CI
ReShape Lifesciences Inc. Announces Resignation of Scott P. Youngstrom as Senior Vice President, Finance and Chief Financial Officer, Effective October 1, 2019	06/08/19	CI
Obalon Therapeutics, Inc. Appoints Bob MacDonald as Chief Retail Officer	10/06/19	CI
Obalon Therapeutics, Inc. Announces Management Changes	22/05/19	CI
ReShape Lifesciences Inc. Appoints Barton P. Bandy as President and Chief Executive Officer	01/04/19	CI
Dan W. Gladney to Resign as President and Chief Executive Officer of Reshape Lifesciences Inc., Effective as of March 31, 2019	28/01/19	CI
Obalon Therapeutics, Inc. Announces Promotion of Amy Vandenberg to Chief Clinical & Regulatory Affairs Officer	03/01/19	CI
Obalon Therapeutics, Inc. Announces Executive Changes	02/01/19	CI
Obalon Therapeutics, Inc. Announces Executive Appointments	02/11/18	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders ReShape Lifesciences Inc.

Equities

RSLS

US76090R2004

Insiders

Filters